Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026
May 1, 2026 - 00:23
FREMONT, Calif., April 30, 2026 -- Alamar Biosciences, Inc., a company focused on precision proteomics and early disease detection, has announced it will release its financial results for the first quarter of 2026 before the market opens on Friday, May 8, 2026.
The company noted that its first earnings conference call as a publicly traded entity is currently planned for August 2026. That call will cover the financial results for the second quarter of the year.
Alamar Biosciences is working on technologies aimed at identifying disease at its earliest stages through protein analysis. The upcoming report will provide investors with a look at the company's performance for the first three months of 2026.
MORE NEWS
June 15, 2026 - 10:41
Finance students’ ‘near-peer’ mentoring raises school pupils’ financial literacyA new survey from the Financial Times has found that business schools are expanding their outreach programs, with a particular focus on financial literacy for younger students. One standout...
June 14, 2026 - 23:03
Toast (TOST): Cash Flow Gains Show How Restaurant Tech Growth Is Becoming More DurableToast, Inc. is drawing attention as a high-growth stock with low debt, appealing to investors looking for expanding businesses that are also improving their bottom line. The company`s restaurant...
June 14, 2026 - 05:10
Iridium’s Aireon Buyout Reshapes Valuation Story And Financial Risk ProfileIridium Communications has announced plans to acquire the remaining stake in Aireon, the air traffic surveillance company it currently holds as a partially owned asset. The move would bring Aireon...
June 13, 2026 - 17:55
MP Materials (MP): 10 Most Promising Mid-Cap Stocks to Buy According to AnalystsMP Materials Corp. (NYSE:MP) has been named one of the 10 most promising mid-cap stocks to buy according to current analyst ratings. The rare earth mining company recently posted its financial and...